05/11
Headlines

Healthcare New Highs: UnitedHealth Group Inc. (NYSE:UNH), WellPoint Inc (NYSE:WLP), Insulet Corporation (NASDAQ:PODD), Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Colin Pettis02 mins

UnitedHealth Group (NYSE:UNH) rose 7.45% last week, as health-care providers are starting to see increased membership, thanks to the Affordable Care Act. UnitedHealth competitor WellPoint, in particular, increased its full-year guidance this past week and expects more than 1 million new health plan members this year. UnitedHealth Group Inc. (NYSE:UNH) stock performance was -0.23% in…

Read More

Healthcare Bullish Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Vermillion (NASDAQ:VRML), Genetic Technologies (NASDAQ:GENE)

Jason Knox02 mins

Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) presented an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California. Biota Pharmaceuticals Inc (NASDAQ:BOTA) stock performance was 10.15% in last session and finished the day at $6.62. Traded volume was 449,674 million shares in the…

Read More

Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

John Meady02 mins

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the…

Read More

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman02 mins

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1…

Read More

Aerospace Stocks: Textron Inc. (NYSE:TXT), Northrop Grumman Corporation (NYSE:NOC), Gencorp Inc (NYSE:GY), Micronet Enertec Technologies (NASDAQ:MICT)

Jayne Crisman02 mins

Cessna Aircraft Company, part of the Textron Aviation segment of Textron Inc. (NYSE:TXT), announced today a new aircraft to add to the company’s popular line of Cessna CJ-series jets. The new CJ3+ from Cessna includes a state-of-the-art fully integrated Garmin G3000™ avionics suite, all-new interiors with a redesigned cabin and cockpit, new pressurization, and new…

Read More

Mega Cap Most Active: Johnson & Johnson (NYSE:JNJ), Apple Inc. (NASDAQ:AAPL), International Business Machines (NYSE:IBM), Microsoft Corporation (NASDAQ:MSFT)

Jason Knox03 mins

Johnson & Johnson (NYSE:JNJ) is an undisputed global leader in the health care industry, benefiting from a rock-solid competitive position in areas such as medical devices and several pharmaceutical markets. Growing health care demand due to an aging population, broadened health insurance coverage, and technological advancements in the industry bode well for Johnson & Johnson…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓